Litcius/Paper detail

Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development

Yuefei Zhu, Jia Li, Zhiqing Pang

2020Asian Journal of Pharmaceutical Sciences59 citationsDOIOpen Access PDF

Abstract

SARS-CoV-2 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population, causing over 5.5 million confirmed cases worldwide. As COVID-19 has posed a global threat with significant human casualties and severe economic losses, there is a pressing demand to further understand the current situation and develop rational strategies to contain the drastic spread of the virus. Although there are no specific antiviral therapies that have proven effective in randomized clinical trials, currently, the rapid detection technology along with several promising therapeutics for COVID-19 have mitigated its drastic transmission. Besides, global institutions and corporations have commenced to parse out effective vaccines for the prevention of COVID-19. Herein, the present review will give exhaustive details of extensive researches concerning the drug discovery and therapeutic options for COVID-19 as well as some insightful discussions of the status of COVID-19.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug developmentClinical trialMedicineIntensive care medicineGlobal population2019-20 coronavirus outbreakPopulationVirologyTransmission (telecommunications)CoronavirusAntiviral drugDiseaseDrugInfectious disease (medical specialty)VirusPharmacologyComputer scienceEnvironmental healthPathologyOutbreakTelecommunicationsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPARP inhibition in cancer therapy